These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32573072)

  • 1. Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells.
    Miyazato K; Tahara H; Hayakawa Y
    Cancer Sci; 2020 Aug; 111(8):2770-2778. PubMed ID: 32573072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenalidomide down regulates the production of interferon-gamma and the expression of inhibitory cytotoxic receptors of human Natural Killer cells.
    Dauguet N; Fournié JJ; Poupot R; Poupot M
    Cell Immunol; 2010; 264(2):163-70. PubMed ID: 20621290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.
    Davies FE; Raje N; Hideshima T; Lentzsch S; Young G; Tai YT; Lin B; Podar K; Gupta D; Chauhan D; Treon SP; Richardson PG; Schlossman RL; Morgan GJ; Muller GW; Stirling DI; Anderson KC
    Blood; 2001 Jul; 98(1):210-6. PubMed ID: 11418482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma.
    Malaisé M; Rovira J; Renner P; Eggenhofer E; Sabet-Baktach M; Lantow M; Lang SA; Koehl GE; Farkas SA; Loss M; Agha A; Campistol JM; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2014 Feb; 192(4):1954-61. PubMed ID: 24415778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of thalidomide and its analogues: implications for anticancer therapy.
    Teo SK
    AAPS J; 2005 Mar; 7(1):E14-9. PubMed ID: 16146335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
    Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
    Front Immunol; 2018; 9():977. PubMed ID: 29780393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.
    Reddy N; Hernandez-Ilizaliturri FJ; Deeb G; Roth M; Vaughn M; Knight J; Wallace P; Czuczman MS
    Br J Haematol; 2008 Jan; 140(1):36-45. PubMed ID: 17995965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.
    Smyth MJ; Cretney E; Takeda K; Wiltrout RH; Sedger LM; Kayagaki N; Yagita H; Okumura K
    J Exp Med; 2001 Mar; 193(6):661-70. PubMed ID: 11257133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunomodulatory effects of lenalidomide].
    Handa H; Saitoh T; Murakami H
    Nihon Rinsho; 2015 Jan; 73(1):156-61. PubMed ID: 25626322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
    Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
    J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.
    Desbois M; Béal C; Charrier M; Besse B; Meurice G; Cagnard N; Jacques Y; Béchard D; Cassard L; Chaput N
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32532840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model.
    Hernandez-Ilizaliturri FJ; Reddy N; Holkova B; Ottman E; Czuczman MS
    Clin Cancer Res; 2005 Aug; 11(16):5984-92. PubMed ID: 16115943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-1 expression is essential for natural killer cells to suppress metastasis.
    Ksienzyk A; Neumann B; Nandakumar R; Finsterbusch K; Grashoff M; Zawatzky R; Bernhardt G; Hauser H; Kröger A
    Cancer Res; 2011 Oct; 71(20):6410-8. PubMed ID: 21900395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic Receptor P2Y
    Li Z; Gao Y; He C; Wei H; Zhang J; Zhang H; Hu L; Jiang W
    J Immunol; 2021 Sep; 207(6):1555-1565. PubMed ID: 34426542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
    J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
    Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
    J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application.
    Hayashi T; Hideshima T; Akiyama M; Podar K; Yasui H; Raje N; Kumar S; Chauhan D; Treon SP; Richardson P; Anderson KC
    Br J Haematol; 2005 Jan; 128(2):192-203. PubMed ID: 15638853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
    Markovic SN; Murasko DM
    Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.
    Payvandi F; Wu L; Naziruddin SD; Haley M; Parton A; Schafer PH; Chen RS; Muller GW; Hughes CC; Stirling DI
    J Interferon Cytokine Res; 2005 Oct; 25(10):604-16. PubMed ID: 16241859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.